Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Annovis Bio, Inc. shareholders approved Ratification of the Company's Independent Auditors at the 2026-06-17 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
The ratification of the appointment of Ernst & Young LLP was approved by stockholders by the following vote: For Against Abstain 20,634,176 568,155 502,782
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Annovis Bio, Inc. shareholders approved Advisory (Non-Binding) Vote on the Compensation of the Company's Named Executive Officers at the 2026-06-17 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
The compensation of the Company's named executive officers was approved b y the stockholders o n an advisory (non-binding basis), by the following vote: Broker Non-Vote For Against Abstain Broker Non-Vote 8,067,931 901,342 185,701 12,550,139
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Annovis Bio, Inc. shareholders approved Election of Directors at the 2026-06-17 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
Election of Directors All of the following five nominees were elected to the Company's Board of Directors, in accordance with the voting results listed below, to serve for a term of one year, until the next Annual Meeting and until their successors have been duly elected and have qualified.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Annovis Bio, Inc. shareholders approved Amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan to increase the number of shares that may be issued under the Plan from 4,000,000 to 5,500,000 and to increase the maximum number of shares that may be awarded in any one year from 400,000 to 600,000 shares at the 2026-06-17 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
The amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan to i ncrease the number of shares that may be issued under the Plan from 4,000,000 to 5,500,000 and to increase the maximum number of shares that may be awarded in any one year from 400,000 to 600,000 shares, was approved by stockholders by the following vote: For Against Abstain Broker Non-Vote 8,089,891 899,671 165,409 12,550,142
View on SEC.gov